---
$id: https://graph.org.ai/products/commodity/51151642
$type: Product
source: UNSPSC
code: "51151642"
title: "Flavoxate"
class: "51151600"
classTitle: "Cholinergic blocking agents"
family: "51150000"
familyTitle: "Autonomic nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Flavoxate

**UNSPSC Code**: 51151642
**Class**: [Cholinergic blocking agents](Cholinergic blocking agents.mdx)
**Family**: [Autonomic nervous system drugs](../Autonomic nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an antimuscarinic agent with the molecular formula C24H25NO4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 3E74Y80MEY, chemically known as 4h-1-benzopyran-8-carboxylic acid, 3-methyl-4-oxo-2-phenyl-, 2-piperidinoethyl ester, hydrochloride but generally known as flavoxate, which bears US NIH Compound Identifier 3354. European Medicines Agency schedules Flavoxate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07635MIG. The term FLAVOXATE is an International Non-Proprietary Name. World Health Organization schedules flavoxate in its Anatomical Therapeutic Chemical (ATC) Classification. FLAVOXATE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule flavoxate under HS 29349990 and SITC 51579. As of Q4 2014, FLAVOXATE remains the US FDA Preferred Term for this commodity. Flavoxate bears US NLM identifiers UMLS ID C0016225 and NCI Concept Code C61765. SMILES: O(CCN1CCCCC1)C(=O)C1C2OC(C(C(=O)C2CCC1)C)C1CCCCC1.

